|
|
| 3. Quantitative Toxicological |
|
| Assessment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-Cancer Toxicity (has a threshold) |
||||||||||||||
| Determine which species, durations, and |
||||||||||||||
| endpoints have been studied |
||||||||||||||
| |
||||||||||||||
| Identify the most sensitive effect |
||||||||||||||
| No Observed Adverse Effect Level: NOAEL |
||||||||||||||
| (or Lowest Observed Adverse Effect Level: |
||||||||||||||
| LOAEL) |
||||||||||||||
| |
||||||||||||||